IBN
Închide

Lista articolelor cu rezumate în limba engleza

Print PDF
Afisarea articolelor: 1-1(1)
2021
1.

Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraineon migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis

. Headache Medicine Connections. 2021, nr. 2(1), 30-23. ISSN 2754-2580. (Cat. )
 
 

1-1 of 1